Advancing delivery of RNA therapeutics with cationizable xenopeptides
Nucleic Acid Insights 2024; 1(9), 285–291
DOI: 10.18609/nai.2024.035
Published: 24 September
Interview
Ernst Wagner
In this interviewRóisin McGuigan, Editor, Nucleic Acid Insights, speaks toErnst Wagner, Chair of Pharmaceutical Biotechnology, Department of Pharmacy and Center of Nanoscience at LMU Munich, exploring advances in non-viral nucleic acid delivery systems and focusing on polycationic carriers and novel formulations including lipo-xenopeptides.